ArticleThe Journal of clinical investigation2024

TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase.

Suowen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.